Cost Effectiveness Analysis [ocac]    
strategies [menp]    
Hepatitis C screening [topp]    
French [lang]    
Blood [tisu]    
Recipient [humn]    
Context [fndg]    
Health Resources [idcn]    
variations [qlco]    
Medical [hlca]    
practices [menp]    
Study [mnob]    
Cost Effectiveness [qnco]    
Screening [hlca]    
strategies [menp]    
HEPATITIS C VIRUS [virs]    
Blood [tisu]    
Recipient [humn]    
Methods [inpr]    
Cost Effectiveness [qnco]    
Test [lbpr]    
Nine [qnco]    
Screening [hlca]    
strategies [menp]    
Survival [acty]    
Categories [inpr]    
Models [inpr]    
Methods [inpr]    
Marginal [spco]    
Cost Effectiveness [qnco]    
RATIO [qnco]    
Estimated [qnco]    
Screening [hlca]    
strategies [menp]    
HEPATITIS C VIRUS [virs]    
Serology [bmod]    
Enzyme-Linked Immunosorbent Assay [lbpr]    
confirmation [qlco]    
Detection [topp]    
Virus-RNA [virs]    
Dominant [ftcn]    
strategy [menp]    
Marginal [spco]    
Cost Effectiveness [qnco]    
Ratios [qnco]    
Subject [grup]    
Low [qlco]    
Transfusion [topp]    
Patients [podg]    
French Franc [qnco]    
Life [idcn]    
YEAR [tmco]    
Gained [qnco]    
Sensitivity [patf]    
Marginal [spco]    
Cost Effectiveness [qnco]    
RATIO [qnco]    
Survival Rates [qnco]    
LOWER [spco]    
Marginal [spco]    
Cost Effectiveness [qnco]    
RATIO [qnco]    
Estimated [qnco]    
French Franc [qnco]    
Life [idcn]    
YEAR [tmco]    
Gained [qnco]    
Study [mnob]    
Costs [qnco]    
Few [qnco]    
Life [idcn]    
YEARS [tmco]    
Gained [qnco]    
Dominant [ftcn]    
strategy [menp]    
Favorable [qlco]    
risk Group [popg]    
NEW [qlco]    
carried [acty]    
Out [spco]    
NEW [qlco]    
Screening [hlca]    
Therapeutic [topp]    
strategies [menp]    
